Heart rhythm study for patients getting mitral valve surgery
Part of Heart & circulation clinical trials.
This study looks at heart rhythm problems in people having mitral valve surgery to fix a leaky valve. It may help doctors better understand who is at risk for dangerous rhythms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You need mitral valve surgery for a leaking valve caused by wear and tear (degenerative disease)
- You must have a condition called arrhythmogenic mitral valve prolapse or be a control without it
- You cannot have other serious heart valve disease, heart muscle disease, or uncontrolled irregular heartbeats
- You must be able to have a heart MRI
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing if a special heart monitor can help patients who need mitral valve repair surgery. If you are scheduled for this surgery, the monitor will be placed during your procedure to track your heart function and recovery.
This study looks at how long a new mitral valve treatment/device can stay working in people with moderate-to-severe or severe mitral valve leak. It may help avoid or delay surgery for people considered higher risk for mitral valve repair.
This study looks at how well CT scans and 3D echo (ultrasound) measure the mitral valve ring before surgery for severe mitral valve leakage. It may help doctors better plan valve repair.
This study collects and compares real-world results to help doctors choose the best treatment for mitral valve “leakiness.” If you have clinically significant mitral insufficiency and have already had a specific heart procedure screening, your echocardiogram results may be used to understand outcomes over at least a month.
This trial studies severe secondary mitral valve leaking and uses heart imaging to predict how well the heart and symptoms improve after a less-invasive valve procedure. It may help doctors better forecast who benefits most from this repair.
This trial focuses on people with severe mitral valve narrowing or leaking who still have symptoms even after the best usual medications. It may help find better care and measure health outcomes when surgery is judged too risky or not suitable.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.